000130465 001__ 130465
000130465 005__ 20240228143435.0
000130465 0247_ $$2doi$$a10.1002/gcc.22344
000130465 0247_ $$2pmid$$apmid:26841698
000130465 0247_ $$2ISSN$$a1045-2257
000130465 0247_ $$2ISSN$$a1098-2264
000130465 0247_ $$2altmetric$$aaltmetric:5099293
000130465 037__ $$aDKFZ-2017-05544
000130465 041__ $$aeng
000130465 082__ $$a570
000130465 1001_ $$0P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aSahm, Felix$$b0$$eFirst author$$udkfz
000130465 245__ $$aSomatic mutations of DICER1 and KMT2D are frequent in intraocular medulloepitheliomas.
000130465 260__ $$aNew York, NY$$bWiley-Liss$$c2016
000130465 3367_ $$2DRIVER$$aarticle
000130465 3367_ $$2DataCite$$aOutput Types/Journal article
000130465 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1524813394_6737
000130465 3367_ $$2BibTeX$$aARTICLE
000130465 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000130465 3367_ $$00$$2EndNote$$aJournal Article
000130465 520__ $$aIntraocular medulloepithelioma (IO-MEPL) is an uncommon embryonal neuroepithelial neoplasm of the eye. Little is known about the cytogenetics, molecular biology, and pathogenesis of this tumor. In the present study we investigated the mutational landscape of 19 IO-MEPL using targeted next-generation sequencing. Routinely prepared paraffin-embedded samples were assessed with high-coverage genome sequencing on the Illumina NextSeq 500 platform using a customized gene panel set covering the coding region of 130 genes. This revealed several notable genomic alterations, including mutations of DICER1 (6 tumors) and KMT2D (also known as MLL2; 5 tumors)-which are frequently recurrent and mutually exclusive molecular events for IO-MEPL. Non-recurrent mutations in the cancer-associated genes BRCA2, BRCA1, NOTCH2, CDH1, and GSE1 were also identified. IO-MEPL samples harboring a DICER1 mutation disclosed few chromosomal alterations and formed a separate DNA methylation cluster, indicating potential differences in genetic and epigenetic events arising perhaps from the presence of this aberration in the tumor genome. The high proportion of recurrent somatic DICER1 and KMT2D mutations in this series of sporadic IO-MEPL points to their likely important roles in the molecular pathogenesis of these rare embryonal tumors, and perhaps suggests the existence of distinct molecular variants of IO-MEPL. Although the precise role of these recurrent mutations in the development of IO-MEPL, and their relationship to pro-oncogenic molecular mechanisms, have yet to be determined, unraveling their roles could eventually be exploited for nonsurgical therapies of these neoplasms.
000130465 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000130465 588__ $$aDataset connected to CrossRef, PubMed,
000130465 650_7 $$2NLM Chemicals$$aDNA-Binding Proteins
000130465 650_7 $$2NLM Chemicals$$aMLL2 protein, human
000130465 650_7 $$2NLM Chemicals$$aNeoplasm Proteins
000130465 650_7 $$0EC 3.1.26.3$$2NLM Chemicals$$aDICER1 protein, human
000130465 650_7 $$0EC 3.1.26.3$$2NLM Chemicals$$aRibonuclease III
000130465 650_7 $$0EC 3.6.4.13$$2NLM Chemicals$$aDEAD-box RNA Helicases
000130465 7001_ $$aJakobiec, Frederick A$$b1
000130465 7001_ $$0P:(DE-He78)b6273c0ba3ae37a4d3d1c6b084797f2e$$aMeyer, Jochen$$b2$$udkfz
000130465 7001_ $$0P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc$$aSchrimpf, Daniel$$b3$$udkfz
000130465 7001_ $$aEberhart, Charles G$$b4
000130465 7001_ $$0P:(DE-He78)744146d3b5a3df1e0ac555e5bf1ee5cc$$aHovestadt, Volker$$b5$$udkfz
000130465 7001_ $$0P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aCapper, David$$b6$$udkfz
000130465 7001_ $$0P:(DE-He78)b84967c4f073b71405404f3719c788cd$$aLambo, Sander$$b7$$udkfz
000130465 7001_ $$aRyzhova, Marina$$b8
000130465 7001_ $$aSchüller, Ulrich$$b9
000130465 7001_ $$aZheludkova, Olga$$b10
000130465 7001_ $$aKumirova, Ella$$b11
000130465 7001_ $$0P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c$$aLichter, Peter$$b12$$udkfz
000130465 7001_ $$0P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$avon Deimling, Andreas$$b13$$udkfz
000130465 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David$$b14$$udkfz
000130465 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan$$b15$$udkfz
000130465 7001_ $$0P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aKool, Marcel$$b16$$udkfz
000130465 7001_ $$0P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aKorshunov, Andrey$$b17$$eLast author$$udkfz
000130465 773__ $$0PERI:(DE-600)1492641-6$$a10.1002/gcc.22344$$gVol. 55, no. 5, p. 418 - 427$$n5$$p418 - 427$$tGenes, chromosomes & cancer$$v55$$x1045-2257$$y2016
000130465 909CO $$ooai:inrepo02.dkfz.de:130465$$pVDB
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b6273c0ba3ae37a4d3d1c6b084797f2e$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)744146d3b5a3df1e0ac555e5bf1ee5cc$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b84967c4f073b71405404f3719c788cd$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000130465 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000130465 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000130465 9141_ $$y2016
000130465 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000130465 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bGENE CHROMOSOME CANC : 2015
000130465 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000130465 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000130465 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000130465 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000130465 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000130465 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000130465 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000130465 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000130465 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000130465 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000130465 9201_ $$0I:(DE-He78)G380-20160331$$kG380$$lKKE Neuropathologie$$x0
000130465 9201_ $$0I:(DE-He78)B060-20160331$$kB060$$lMolekulare Genetik$$x1
000130465 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x2
000130465 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x3
000130465 980__ $$ajournal
000130465 980__ $$aVDB
000130465 980__ $$aI:(DE-He78)G380-20160331
000130465 980__ $$aI:(DE-He78)B060-20160331
000130465 980__ $$aI:(DE-He78)B062-20160331
000130465 980__ $$aI:(DE-He78)L101-20160331
000130465 980__ $$aUNRESTRICTED